224 related articles for article (PubMed ID: 23312949)
21. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
[TBL] [Abstract][Full Text] [Related]
24. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH
Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Wang SF; Yin Y; Zhang YL; Mi SW; Zhao MY; Lv PC; Wang BZ; Zhu HL
Eur J Med Chem; 2015 Mar; 93():291-9. PubMed ID: 25703297
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors.
Liu XH; Jia YM; Song BA; Pang ZX; Yang S
Bioorg Med Chem Lett; 2013 Feb; 23(3):720-3. PubMed ID: 23265905
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
Zhang F; Wang XL; Shi J; Wang SF; Yin Y; Yang YS; Zhang WM; Zhu HL
Bioorg Med Chem; 2014 Jan; 22(1):468-77. PubMed ID: 24286761
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents.
Li X; Lu X; Xing M; Yang XH; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Jun; 22(11):3589-93. PubMed ID: 22572580
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
Fullam E; Talbot J; Abuhammed A; Westwood I; Davies SG; Russell AJ; Sim E
Bioorg Med Chem Lett; 2013 May; 23(9):2759-64. PubMed ID: 23518278
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors.
Dong JJ; Li QS; Wang SF; Li CY; Zhao X; Qiu HY; Zhao MY; Zhu HL
Org Biomol Chem; 2013 Oct; 11(37):6328-37. PubMed ID: 23942809
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Li J; Shi JB; Song BA; Qi XB
Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648
[TBL] [Abstract][Full Text] [Related]
32. Molecular Modeling and Evaluation of Novel Dibenzopyrrole Derivatives as Telomerase Inhibitors and Potential Drug for Cancer Therapy.
Kalathiya U; Padariya M; Baginski M
IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(6):1196-207. PubMed ID: 26357055
[TBL] [Abstract][Full Text] [Related]
33. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
Zeng H; Zhang H
J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors.
Fan ZF; Ho ST; Wen R; Fu Y; Zhang L; Wang J; Hu C; Shaw PC; Liu Y; Cheng MS
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480619
[TBL] [Abstract][Full Text] [Related]
35. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL
Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
[TBL] [Abstract][Full Text] [Related]
39. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
[TBL] [Abstract][Full Text] [Related]
40. Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure.
Castillo-González D; Cabrera-Pérez MA; Pérez-González M; Morales Helguera A; Durán-Martínez A
Eur J Med Chem; 2009 Dec; 44(12):4826-40. PubMed ID: 19726112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
